Cargando…
S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer
Angiogenesis in solid tumors is divided into two modes: endothelium-dependent vessel (EDV) and vasculogenic mimicry (VM). Sphingosine-1-phosphate receptor 1 (S1PR1) plays a vital role on EDV in a variety of human tumors. However, the relationship between S1PR1 and VM is not clear. The aim of this st...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393557/ https://www.ncbi.nlm.nih.gov/pubmed/30814488 http://dx.doi.org/10.1038/s41419-019-1411-x |
_version_ | 1783398717772005376 |
---|---|
author | Liu, Shuang Ni, Chunsheng Zhang, Danfang Sun, Huizhi Dong, Xueyi Che, Na Liang, Xiaohui Chen, Chen Liu, Fang Bai, Jingru Lin, Xian Zhao, Xiulan Sun, Baocun |
author_facet | Liu, Shuang Ni, Chunsheng Zhang, Danfang Sun, Huizhi Dong, Xueyi Che, Na Liang, Xiaohui Chen, Chen Liu, Fang Bai, Jingru Lin, Xian Zhao, Xiulan Sun, Baocun |
author_sort | Liu, Shuang |
collection | PubMed |
description | Angiogenesis in solid tumors is divided into two modes: endothelium-dependent vessel (EDV) and vasculogenic mimicry (VM). Sphingosine-1-phosphate receptor 1 (S1PR1) plays a vital role on EDV in a variety of human tumors. However, the relationship between S1PR1 and VM is not clear. The aim of this study is to investigate S1PR1 on the regulation of EDV and mimicry formation in breast cancer. Here we show that S1PR1 phosphorylates the complex of VE-cadherin to regulate the switch of EDV and mimicry formation. Suppression of S1PR1 impairs EDV, but contributes to the generation of VM, invasion, and metastasis in vivo and vitro. By inhibiting RhoA activation, the S1PR1/VE-cadherin signaling is blocked. S1PR1 controls VE-cadherin expression and EDV via RhoA activation. Moreover, the low expression of S1PR1 correlates with VM and poor prognosis in breast cancer patient. The results show that S1PR1 regulated RhoA activation to accelerate VE-cadherin phosphorylation (Y731), leading to increased EDV and reduced VM in breast cancer. S1PR1 may provide a new thinking direction for antiangiogenic therapy for patients with breast cancer. |
format | Online Article Text |
id | pubmed-6393557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63935572019-02-28 S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer Liu, Shuang Ni, Chunsheng Zhang, Danfang Sun, Huizhi Dong, Xueyi Che, Na Liang, Xiaohui Chen, Chen Liu, Fang Bai, Jingru Lin, Xian Zhao, Xiulan Sun, Baocun Cell Death Dis Article Angiogenesis in solid tumors is divided into two modes: endothelium-dependent vessel (EDV) and vasculogenic mimicry (VM). Sphingosine-1-phosphate receptor 1 (S1PR1) plays a vital role on EDV in a variety of human tumors. However, the relationship between S1PR1 and VM is not clear. The aim of this study is to investigate S1PR1 on the regulation of EDV and mimicry formation in breast cancer. Here we show that S1PR1 phosphorylates the complex of VE-cadherin to regulate the switch of EDV and mimicry formation. Suppression of S1PR1 impairs EDV, but contributes to the generation of VM, invasion, and metastasis in vivo and vitro. By inhibiting RhoA activation, the S1PR1/VE-cadherin signaling is blocked. S1PR1 controls VE-cadherin expression and EDV via RhoA activation. Moreover, the low expression of S1PR1 correlates with VM and poor prognosis in breast cancer patient. The results show that S1PR1 regulated RhoA activation to accelerate VE-cadherin phosphorylation (Y731), leading to increased EDV and reduced VM in breast cancer. S1PR1 may provide a new thinking direction for antiangiogenic therapy for patients with breast cancer. Nature Publishing Group UK 2019-02-27 /pmc/articles/PMC6393557/ /pubmed/30814488 http://dx.doi.org/10.1038/s41419-019-1411-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Liu, Shuang Ni, Chunsheng Zhang, Danfang Sun, Huizhi Dong, Xueyi Che, Na Liang, Xiaohui Chen, Chen Liu, Fang Bai, Jingru Lin, Xian Zhao, Xiulan Sun, Baocun S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer |
title | S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer |
title_full | S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer |
title_fullStr | S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer |
title_full_unstemmed | S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer |
title_short | S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer |
title_sort | s1pr1 regulates the switch of two angiogenic modes by ve-cadherin phosphorylation in breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393557/ https://www.ncbi.nlm.nih.gov/pubmed/30814488 http://dx.doi.org/10.1038/s41419-019-1411-x |
work_keys_str_mv | AT liushuang s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT nichunsheng s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT zhangdanfang s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT sunhuizhi s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT dongxueyi s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT chena s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT liangxiaohui s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT chenchen s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT liufang s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT baijingru s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT linxian s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT zhaoxiulan s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer AT sunbaocun s1pr1regulatestheswitchoftwoangiogenicmodesbyvecadherinphosphorylationinbreastcancer |